相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
314
- 英文名:
Dihydroergotoxine mesylate
- CAS号:
8067-24-1
- 保质期:
2年
- 供应商:
北京百奥莱博科技有限公司
- 保存条件:
-20℃,有效期2年,溶入溶剂后-20℃
- 规格:
1mL(10mM)|100mg
特别提示:包括Dihydroergotoxine mesylate在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
产品名称:Dihydroergotoxine mesylate
英文名称:Dihydroergotoxine mesylate
产品货号:M05964
产品规格:1mL(10mM)|100mg
Dihydroergotoxine mesylate是系列生物碱盐混合物,对GABAA受体高结合活性。
注:本品仅可用于科研实验,严禁用于临床医疗及其他用途!
CAS号:8067-24-1
别名:Ergoloid mesylates
纯度:98.0%
分子式:C₁₂₃H₁₅₆N₂₀O₂₃S
分子量:2314.74
结构式:
储存条件:-20℃,有效期2年,溶入溶剂后-20℃请尽量在一个月内使用。
除了Dihydroergotoxine mesylate,Ergoloid mesylates,我公司还供应以下相关产品:
M00975 雌激素受体调节剂(Toremifene Citrate) 1mL(10mM)|100mg|500mg
M01834 Isobavachalcone 1mL(10mM)|5mg|10mg|25mg
M02347 SCH900776 S-isomer 1mL(10mM)|2mg|5mg|10mg|50mg
M02785 α*上腺素阻断剂(Prazosin hydrochloride) 1mL(10mM)|100mg|200mg|500mg
M02816 *上腺素受体拮抗剂(Sotalol hydrochloride) 1mL(10mM)|50mg|100mg|200mg|500mg|1g
M03065 β1*上腺素受体阻断剂(Betaxolol) 1mL(10mM)|10mg|50mg|100mg
M03386 Gliquidone 1mL(10mM)|50mg|100mg
M03671 Lasalocid 1mL(10mM)|5mg|10mg
M03704 Cefoperazone 1mL(10mM)|1g|5g
M03778 Benzyl benzoate 1mL(10mM)|100mg
M04526 人H1受体拮抗剂(Desloratadine) 1mL(10mM)|50mg|100mg|500mg
M04681 Hydroxyzine双盐酸盐是组胺H1受体拮抗剂 1mL(10mM)|100mg|500mg
M04869 抗组胺剂(Pheniramine Maleate) 1mL(10mM)|100mg|500mg
M05674 Glutathione oxidized 1mL(10mM)|100mg
M05847 谷氨酸盐拮抗剂(Riluzole) 1mL(10mM)|100mg|500mg
M05965 Oxybate sodium 1mL(10mM)|10mg
M06152 GABA A受体调节剂(Lorediplon) 1mL(10mM)|5mg|10mg|50mg|100mg
M06161 ZSET1446 1mL(10mM)|1mg|5mg|10mg|25mg|50mg
M06198 Ramosetron Hydrochloride 1mL(10mM)|10mg|50mg
M06633 毒蕈碱乙酰胆碱受体(mAChR)拮抗剂 1mL(10mM)|100mg|500mg
M07046 非钾离子通道阻断剂(4-Aminopyridine) 1mL(10mM)|5g|10g
M07140 TIC10异构体(TIC10 isomer) 1mL(10mM)|5mg|10mg|50mg|100mg
M07265 Madecassoside 1mL(10mM)|10mg|50mg|100mg|200mg
M07462 Iloperidone metabolite Hydroxy Iloperidone 1mL(10mM)|5mg|10mg|50mg
M07503 Meglumine 1mL(10mM)|50g
M07543 TMB monosulfate 1mL(10mM)|100mg
HR8260 细胞粘附检测试剂盒 500T/1000T
BTN160224 5%*醛溶液 250mL
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection of BCR-ABL Mutations and Resistance to Imatinib Mesylate
The major mechanism of imatinib resistance for patients with chronic myeloid leukemia (CML) is clonal expansion of leukemic cells with mutations in the Bcr-Abl fusion tyrosine kinase that reduce the capacity of imatinib to inhibit kinase
-4 and C-5 centers ( 3 ). After formatron of the mesylate, from the recycled material the amine function is introduced through azrde displacement of the mesylate, followed by reduction ( 4 ) and protectron with the t -BOC group. Finally, the lactone
Inhibitors of Cellular Signaling Targets: Designs and Limitations
. Because of their central role in cellular signaling, as well as their primary role in disease progression, protein kinases are attractive therapeutic targets (2 ,3 ). Seven molecules targeting protein kinases, imatinib mesylate (Gleevec) and trastuzumab (Herceptin
技术资料暂无技术资料 索取技术资料









